Intricacies of retroperitoneal lymph node dissection for testis cancer

被引:6
作者
Alsyouf, Muhannad [1 ]
Daneshmand, Siamak [1 ]
机构
[1] Univ Southern Calif, USC Dept Urol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA
关键词
germ cell tumor; metastases; retroperitoneal lymph node dissection; retroperitoneal neoplasms; testicular cancer; MIDLINE EXTRAPERITONEAL APPROACH; GERM-CELL TUMOR; TESTICULAR CANCER; EJACULATION; MANAGEMENT; SURGERY; COMPLICATIONS; RESECTION;
D O I
10.1097/MOU.0000000000000938
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Retroperitoneal lymph node dissection (RPLND) and retroperitoneal tumor resection for germ cell cancer are complex operations requiring experience and expertise in surgical techniques necessary to achieve complete resection while minimizing morbidity. This article reviews the intricacies of RPLND for testis cancer. Recent findings Surgical management of advanced testis cancer begins with an intimate understanding of retroperitoneal anatomy and the various techniques necessary to safely extirpate tumors. Preoperatively patients should undergo comprehensive counseling and obtain up-to-date imaging along with tumor markers to assist in surgical planning and evaluation of extraretroperitoneal (ERP) disease. Surgeons must be well versed in nerve-sparing techniques to maintain ejaculatory function. Newer techniques using a midline extraperitoneal technique minimizes morbidity and length of hospital stay. Special consideration should be given to the possibility of encountering ERP disease in advanced germ cell tumors, with management of these cases in tertiary care centers with multidisciplinary teams. The perioperative care of the testis cancer patient undergoing RPLND is complex. The goal is to achieve complete resection to render patients disease free while minimizing surgical and long-term morbidity. Advanced testis cancer patients should be managed at tertiary care facilities with surgical expertise and access to multidisciplinary care.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 38 条
[1]   Thoracoabdominal resection of retrocrural residual cancers [J].
Albers, P ;
Höltl, W ;
Heidenreich, A ;
Aharinejad, S .
AKTUELLE UROLOGIE, 2004, 35 (02) :141-150
[2]   Cryopreservation of sperm: Indications, methods and results [J].
Anger, JT ;
Gilbert, BR ;
Goldstein, M .
JOURNAL OF UROLOGY, 2003, 170 (04) :1079-1084
[3]  
Baniel J, 1999, SEMIN SURG ONCOL, V17, P263, DOI 10.1002/(SICI)1098-2388(199912)17:4<263::AID-SSU7>3.0.CO
[4]  
2-6
[5]   SOME USES OF LYMPHANGIOGRAPHY IN MANAGEMENT OF TESTICULAR TUMORS [J].
BUSCH, FM ;
SAYEGH, ES ;
CHENAULT, OW .
JOURNAL OF UROLOGY, 1965, 93 (04) :490-&
[6]   Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection? [J].
Calaway, Adam C. ;
Foster, Richard S. ;
Tong, Yan ;
Masterson, Timothy A. ;
Bihrle, Richard ;
Cary, Clint .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (04) :305-312
[7]   Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection [J].
Carver, Brett S. ;
Shayegan, Bobby ;
Eggener, Scott ;
Stasi, Jason ;
Motzer, Robert J. ;
Bosl, George J. ;
Sheinfeld, Joel .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) :4365-4369
[8]   Management of post-chemotherapy extra-retroperitoneal residual masses [J].
Carver, Brett S. ;
Sheinfeld, Joel .
WORLD JOURNAL OF UROLOGY, 2009, 27 (04) :489-492
[9]   Role of surgical resection for refractory germ cell tumors [J].
Daneshmand, Siamak .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (08) :370-378
[10]   Adjuvant Surgery in Testicular Cancer Patients Undergoing Postchemotherapy Retroperitoneal Lymph Node Dissection [J].
Djaladat, Hooman ;
Nichols, Craig ;
Daneshmand, Siamak .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (07) :2388-2393